Volume 27, Number 7—July 2021
Research Letter
Anthemosoma garnhami in an HIV-Infected Man from Zimbabwe Living in South Africa
Table
Laboratory findings over time for an HIV-positive patient from Zimbabwe living in South Africa who was infected with the rodent piroplasm Anthemosoma garnhami
Laboratory test | Dates |
Reference values | ||||
---|---|---|---|---|---|---|
2019 May 31 | 2019 Jun 7* | 2019 Jun 20 | 2020 Aug 31† | 2020 Nov 11 | ||
Hemoglobin, g/L | 45 | 40 | 92 | 59 | 96 | 132–173 |
Mean cell volume, × 1015/L | 82 | 73 | 84 | 81 | 84 | 80–99 |
Leukocyte count, × 109/L | 0.34 | 2.4 | 3.6 | 2.2 | 3.8 | 4–11 |
Platelet count, × 109/L | 123 | 140 | 184 | 56 | 103 | 137–373 |
Reticulocytes, % | 5.6 | 0.5–1.5 | ||||
Creatinine, mg/dL | 0.79 | 0.5–1.5 | ||||
Total bilirubin, mg/dL | 0.41 | 0.3–1.0 | ||||
Aspartate transaminase, U/L | 111 | 10–30 | ||||
Alanine transaminase, U/L | 19 | 47 | 10–40 | |||
Lactate dehydrogenase, U/L | 922 | 100–200 | ||||
Haptoglobin, g/L | <0.1 | 0.3–2.0 | ||||
CD4, cells/mm3 | 70 | 195 | 500–1,200 | |||
HIV ELISA | Positive | |||||
Sputum Xpert MTB/RIF‡ | Negative |
*Date of treatment initiation. †Date of recrudescence and retreatment initiation. ‡Mycobacterium tuberculosis and rifampin resistance testing (Cepheid, https://www.cepheid.com).